N/A
N=54
Evaluation of Deposits on Contact Lenses Worn Extended Wear
Myopia
Bottom Line
View on ClinicalTrials.gov: NCT00725530 ↗Enrolled (actual)
54
Serious AEs
0.0%
Results posted
Aug 2012
Primary outcome: Primary: Front Surface Lens Deposits — 20; 25; 34; 29 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- balafilcon A contact lens (PureVision) (Device); etafilcon A contact lens (Acuvue2) (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Alcon Research
- Primary completion
- Oct 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Front Surface Lens Deposits |
20; 25; 34; 29 | — |
Summary
The purpose of this study was to measure lipid deposits on commercially marketed contact lenses when worn on an extended wear (overnight) basis for 7 days.
Eligibility Criteria
Inclusion Criteria
- Age 18 or older.
- Visual acuity correctable to 20/30 (Snellen) or better in each eye at distance with contact lenses.
- Successfully wearing hydrogel or silicone hydrogel contact lenses.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria
- Evidence or history of ocular conditions as prescribed in the protocol.
- One functional eye or a monofit lens.
- Any slit-lamp finding score of (1) at the Screening Visit as defined by the protocol.
- Use of concomitant topical ocular prescription or over-the-counter ocular medications.
- History of seasonal allergies with significant ocular side effects.
- Other protocol-defined exclusion criteria may apply.
Data sourced from ClinicalTrials.gov (NCT00725530). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.